Neuropsychological Assessment and Intervention for Childhood and Adolescent Disorders

Neuropsychological Assessment and Intervention for Childhood and Adolescent Disorders......Page 1
Contents......Page 9
Foreword......Page 15
Preface......Page 17
Acknowledgments......Page 19
About the Authors......Page 21
WHAT IS PEDIATRIC NEUROPSYCHOLOGY?......Page 25
NEUROPSYCHOLOGICAL ASSESSMENT......Page 27
INTERPRETATION......Page 33
WHY NEUROPSYCHOLOGICAL ASSESSMENT?......Page 34
LINKING ASSESSMENT TO INTERVENTION......Page 35
CONCLUDING COMMENTS......Page 36
DEFINITION......Page 39
ETIOLOGY......Page 41
COURSE AND PROGNOSIS......Page 47
EVIDENCE-BASED INTERVENTIONS......Page 49
CASE STUDY: COR —DYSLEXIA......Page 52
CONCLUDING COMMENTS......Page 63
DEFINITION......Page 65
ETIOLOGY......Page 68
COURSE AND PROGNOSIS......Page 72
CASE STUDY: CARL—DYSCALCULIA......Page 78
CONCLUDING COMMENTS......Page 86
DEFINITION......Page 87
ETIOLOGY......Page 90
COURSE AND PROGNOSIS......Page 96
EVIDENCE-BASED INTERVENTIONS......Page 101
CASE STUDY: NAYA—DYSPHASIA/SLI......Page 103
CONCLUDING COMMENTS......Page 111
DEFINITION......Page 113
ETIOLOGY......Page 115
COURSE AND PROGNOSIS......Page 124
EVIDENCE-BASED INTERVENTIONS......Page 130
CASE STUDY: JOHN—ASPERGER’S DISORDER......Page 134
CONCLUDING COMMENTS......Page 143
DEFINITION......Page 145
ETIOLOGY......Page 148
COURSE AND PROGNOSIS......Page 151
EVIDENCE-BASED INTERVENTIONS......Page 153
CASE STUDY: EDDIE—ATTENTION-DEFICIT/HYPERACTIVITY DISORDER, COMBINED TYPE......Page 161
CONCLUDING COMMENTS......Page 169
DEFINITION......Page 171
ETIOLOGY......Page 172
COURSE AND PROGNOSIS......Page 176
EVIDENCE-BASED INTERVENTIONS......Page 186
CASE STUDY: MOSES—TOURETTE SYNDROME......Page 191
CONCLUDING COMMENTS......Page 202
DEFINITION......Page 205
COURSE AND PROGNOSIS......Page 208
EVIDENCE-BASED INTERVENTIONS......Page 217
CASE STUDY: GAGE—TRAUMATIC BRAIN INJURY......Page 222
CONCLUDING COMMENTS......Page 230
DEFINITION......Page 231
ETIOLOGY......Page 233
COURSE AND PROGNOSIS......Page 235
EVIDENCE-BASED INTERVENTIONS......Page 241
CASE STUDY: DAVID—LYMPHOCYTIC LEUKEMIA......Page 244
CASE STUDY: JAY—ASTROCYTOMA......Page 252
CONCLUDING COMMENTS......Page 260
DEFINITION......Page 261
ETIOLOGY......Page 263
COURSE AND PROGNOSIS......Page 264
EVIDENCE-BASED INTERVENTIONS......Page 270
CASE STUDY: ZOEY—COMPLEX PARTIAL SEIZURES WITH TEMPORAL LOBE ORIGIN......Page 275
CASE STUDY: LANE—LANDAU-KLEFFNER SYNDROME (EPILEPTIC APHASIA)......Page 284
CONCLUDING COMMENTS......Page 296
DEFINITION......Page 297
ETIOLOGY......Page 298
COURSE AND PROGNOSIS......Page 299
EVIDENCE-BASED INTERVENTIONS......Page 303
CASE STUDY: LANIA—SICKLE CELL DISEASE WITHOUT STROKE......Page 305
CASE STUDY: JED—SICKLE CELL DISEASE WITH STROKE......Page 318
CONCLUDING COMMENTS......Page 329
ETIOLOGY......Page 331
COURSE AND PROGNOSIS......Page 333
EVIDENCE-BASED INTERVENTIONS......Page 341
CASE STUDY: EMILY—EXTREMELY LOW BIRTH WEIGHT......Page 346
CONCLUDING COMMENTS......Page 356
DEFINITION AND ETIOLOGY......Page 359
COURSE AND PROGNOSIS......Page 365
EVIDENCE-BASED INTERVENTIONS......Page 370
CASE STUDY: DEMETRIC—LEAD EXPOSURE......Page 371
CONCLUDING COMMENTS......Page 381
DEFINITION AND ETIOLOGY......Page 383
COURSE AND PROGNOSIS: FASD AND ILLICIT DRUGS FASD......Page 390
CASE STUDY: CALEB—FETAL ALCOHOL SYNDROME......Page 392
COURSE AND PROGNOSIS: ANTIEPILEPTICS AND FVS......Page 401
CASE STUDY: KEISHA—FETAL VALPROATE SYNDROME......Page 403
EVIDENCE-BASED INTERVENTIONS......Page 408
CONCLUDING COMMENTS......Page 409
AUTOSOMAL ABNORMALITIES: DOWN SYNDROME......Page 411
FRAGILE X......Page 416
WILLIAMS SYNDROME......Page 421
ANGELMAN SYNDROME......Page 427
PRADER-WILLI SYNDROME......Page 431
CASE STUDY: GEORGE—ANGELMAN SYNDROME......Page 437
SEX CHROMOSOME DISORDERS......Page 441
CASE STUDY: WALTER—NOONAN SYNDROME......Page 448
CONCLUDING COMMENTS......Page 455
NEUROFIBROMATOSIS......Page 457
CASE STUDY: GINO—NEUROFIBROMATOSIS TYPE 1......Page 462
TUBEROUS SCLEROSIS COMPLEX......Page 472
CASE STUDY: HECTOR—TUBEROUS SCLEROSIS......Page 476
STURGE-WEBER SYNDROME......Page 487
CASE STUDY: JULIANA—STURGE-WEBER SYNDROME......Page 490
CONCLUDING COMMENTS......Page 499
TYPE 1 DIABETES......Page 501
CASE STUDY: SAM—TYPE 1 DIABETES......Page 508
PHENYLKETONURIA......Page 518
CASE STUDY: VINNIE—PKU......Page 523
MUCOPOLYSACCHARIDE DISORDERS......Page 536
CONCLUDING COMMENTS......Page 538
ASSESSMENT TO INTERVENTION PLANNING IN PEDIATRIC NEUROPSYCHOLOGY......Page 541
SUMMARY OF INTERVENTION ISSUES......Page 549
CONCLUSION AND FUTURE DIRECTIONS......Page 551
References......Page 553
Author Index......Page 711
Subject Index......Page 733